News Releases

News Releases

October 31, 2018
MeiraGTx Announces Exclusive Licensing Agreement with National Institutes of Health for Gene Therapy Treatment for Sjögren’s Syndrome and Associated Xerostomia or Xerophthalmia
LONDON and NEW YORK, Oct. 31, 2018 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced an exclusive licensing agreement with the National Institute of Dental and Craniofacial Research (NIDCR), a division of the
October 2, 2018
MeiraGTx to Present at Upcoming Conferences
LONDON and NEW YORK, Oct. 02, 2018 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that it will present at the following conferences: 2018 Cell & Gene Meeting on the Mesa on Thursday, October 4, 2018 at 1:45 p.m.
Displaying 1 - 10 of 17